A coating composition for use in coating implantable medical devices to improve their ability to release bioactive agents in vivo. The coating composition is particularly adapted for use with devices that undergo significant flexion and/or expansion in the course of their delivery and/or use, such a
A coating composition for use in coating implantable medical devices to improve their ability to release bioactive agents in vivo. The coating composition is particularly adapted for use with devices that undergo significant flexion and/or expansion in the course of their delivery and/or use, such as stents and catheters. The composition includes the bioactive agent in combination with a mixture of a first polymer component such as poly(butyl methacrylate) and a second polymer component such as poly(ethylene-co-vinyl acetate).
대표청구항▼
What is claimed is: 1. A composition for coating the surface of a medical device with one or more bioactive agents in a manner that permits the coated surface to release the bioactive agent(s) over time when implanted in vivo, the composition comprising one or more bioactive agents in combination w
What is claimed is: 1. A composition for coating the surface of a medical device with one or more bioactive agents in a manner that permits the coated surface to release the bioactive agent(s) over time when implanted in vivo, the composition comprising one or more bioactive agents in combination with a first polymer component comprising at least one poly(alkyl)(meth)acrylate and a second polymer component comprising poly(ethylene-co-vinyl acetate), wherein the device is one that undergoes flexion and/or expansion in the course of implantation or use in vivo. 2. A composition for coating the surface of a medical device with one or more bioactive agents in a manner that permits the coated surface to release the bioactive agent(s) over time when implanted in vivo, the composition comprising one or more bioactive agents in combination with a first polymer component comprising at least one poly(alkyl)(meth)acrylate and a second polymer component comprising poly(ethylene-co-vinyl acetate), wherein the composition permits the amount and rate of release of agent(s) from the medical device to be controlled by adjusting the relative types and/or concentrations of polymers in the mixture. 3. A composition for coating the surface of a medical device with one or more bioactive agent(s) in a manner that permits the coated surface to release the bioactive agent(s) over time when implanted in vivo, the composition comprising one or more bioactive agent(s) in combination with a first polymer component comprising at least one poly(alkyl)(meth)acrylate and a second polymer component comprising poly(ethylene-co-vinyl acetate), wherein the device is selected from the group consisting of catheters and stents. 4. A composition according to claim 1, 2 or 3 wherein the bioactive agent is selected from the group consisting of thrombin inhibitors, antithrombogenic agents, thrombolytic agents, fibrinolytic agents, vasospasm inhibitors, calcium channel blockers, vasodilators, antihypertensive agents, antimicrobial agents, antibiotics, inhibitors of surface glycoprotein receptors, antiplatelet agents, antimitotics, microtubule inhibitors, anti secretory agents, actin inhibitors, remodeling inhibitors, antisense nucleotides, anti metabolites, antiproliferatives, anticancer chemotherapeutic agents, anti-inflammatory steroid or non-steroidal anti-inflammatory agents, immunosuppressive agents, growth hormone antagonists, growth factors, dopamine agonists, radiotherapeutic agents, peptides, proteins, enzymes, extracellular matrix components, inhibitors, free radical scavengers, chelators, antioxidants, anti polymerases, antiviral agents, photodynamic therapy agents, and gene therapy agents. 5. A composition according to claim 1, 2, or 3 wherein the first and second polymer components are adapted to be mixed to provide a mixture that exhibits an optimal combination of physical characteristics and bioactive release characteristics as compared to the polymers when used alone. 6. A composition according to claim 1, 2, or 3 wherein the amount and rate of release of agent(s) from the medical device can be controlled by adjusting the relative types and/or concentrations of the first polymer component and the second polymer component. 7. A polymeric coating composition comprising a first polymer component comprising at least one poly(alkyl)(meth)acrylate and a second polymer component comprising poly(ethylene-co-vinyl acetate) and one or more bioactive agents and positioned upon the surface of a medical device in a manner that permits the coated surface to release the bioactive agent(s) over time when implanted in vivo, wherein the composition provides sufficient durability and flexibility to be used upon a device is one that undergoes flexion and/or expansion in the course of implantation or use in vivo. 8. A composition according to claim 7 wherein the bioactive release rate from a coated medical device can be manipulated by adjusting the relative concentrations of the first and second polymers. 9. A polymeric coating composition according to claim 7 wherein the coating comprises multiple polymeric layers. 10. A method for providing an implantable medical device with a therapeutic effect, the method comprising the step of providing a medical device having a surface coated with a composition comprising one or more bioactive agents in a manner that permits the coated surface to release the bioactive agent(s) over time when implanted in vivo, the composition comprising one or more bioactive agents in combination with a first polymer component comprising at least one poly(alkyl)(meth)acrylate and a second polymer component comprising poly(ethylene-co-vinyl acetate), wherein the device is one that undergoes flexion and/or expansion in the course of implantation or use in vivo. 11. A method for providing an implantable medical device with a therapeutic effect, the method comprising the step of providing a medical device having a surface of the medical device with a composition comprising one or more bioactive agents in a manner that permits the coated surface to release the bioactive agent(s) over time when implanted in vivo, the composition comprising one or more bioactive agents in combination with a first polymer component comprising at least one poly(alkyl)(meth)acrylate and a second polymer component comprising poly(ethylene-co-vinyl acetate), wherein the composition permits the amount and rate of release of agent(s) from the medical device to be controlled by adjusting the relative types and/or concentrations of polymers in the mixture. 12. A method for providing an implantable medical device with a therapeutic effect, the method comprising the step of providing a medical device having a coated with a composition comprising one or more bioactive agent(s) in a manner that permits the coated surface to release the bioactive agent(s) over time when implanted in vivo, the composition comprising one or more bioactive agent(s) in combination with a first polymer component comprising at least one poly(alkyl)(meth)acrylate and a second polymer component comprising poly(ethylene-co-vinyl acetate), wherein the device is selected from the group consisting of catheters and stents. 13. A method according to claim 10, 11 or 12 wherein the bioactive agent is selected from the group consisting of thrombin inhibitors, antithrombogenic agents, thrombolytic agents, fibrinolytic agents, vasospasm inhibitors, calcium channel blockers, vasodilators, antihypertensive agents, antimicrobial agents, antibiotics, inhibitors of surface glycoprotein receptors, antiplatelet agents, antimitotics, microtubule inhibitors, anti secretory agents, actin inhibitors, remodeling inhibitors, antisense nucleotides, anti metabolites, antiproliferatives, anticancer chemotherapeutic agents, anti-inflammatory steroid or non-steroidal anti-inflammatory agents, immunosuppressive agents, growth hormone antagonists, growth factors, dopamine agonists, radiotherapeutic agents, peptides, proteins, enzymes, extracellular matrix components, inhibitors, free radical scavengers, chelators, antioxidants, anti polymerases, antiviral agents, photodynamic therapy agents, and gene therapy agents. 14. A method according to claim 10, 11, or 12 wherein the first and second polymer components are adapted to be mixed to provide a mixture that exhibits an optimal combination of physical characteristics and bioactive release characteristics as compared to the polymers when used alone. 15. A method according to claim 10, 11, or 12 wherein the amount and rate of release of agent(s) from the medical device can be controlled by adjusting the relative types and/or concentrations of the first and second polymers. 16. A composition for coating the surface of a medical device with a bioactive agent in a manner that permits the coated surface to release the bioactive agent over time when implanted in vivo, the composition comprising a bioactive agent in combination with a plurality of polymers, including a first polymer component comprising at least one poly(alkyl)(meth)acrylate and a second polymer component comprising poly(ethylene-co-vinyl acetate). 17. A composition according to claim 7 or 16 wherein the bioactive agent comprises an antithrombogenic agent. 18. A composition according to claim 7 or 16 wherein the bioactive agent comprises an anti-inflammatory agent. 19. A composition according to claim 7 or 16 wherein the bioactive agent comprises a remodeling inhibitor. 20. A composition according to claim 7 or 16 wherein the bioactive agent comprises an antiproliferative. 21. A combination comprising a medical device coated with a composition according to claim 7 or 16. 22. A combination according to claim 21 wherein the medical device comprises a stent. 23. A combination according to claim 21 wherein the bioactive agent is selected from the group consisting of thrombin inhibitors, antithrombogenic agents, thrombolytic agents, fibrinolytic agents, vasospasm inhibitors, calcium channel blockers, vasodilators, antihypertensive agents, antimicrobial agents, antibiotics, inhibitors of surface glycoprotein receptors, antiplatelet agents, antimitotics, microtubule inhibitors, anti secretory agents, actin inhibitors, remodeling inhibitors, antisense nucleotides, anti metabolites, antiproliferatives, anticancer chemotherapeutic agents, anti-inflammatory steroid or non-steroidal anti-inflammatory agents, immunosuppressive agents, growth hormone antagonists, growth factors, dopamine agonists, radiotherapeutic agents, peptides, proteins, enzymes, extracellular matrix components, inhibitors, free radical scavengers, chelators, antioxidants, anti polymerases, antiviral agents, photodynamic therapy agents, and gene therapy agents. 24. A combination according to claim 21 or 22 wherein the bioactive agent comprises an antithrombogenic agent. 25. A combination according to claim 21 or 22 wherein the bioactive agent comprises an anti-inflammatory agent. 26. A composition according to claim 21 or 22 wherein the bioactive agent comprises a remodeling inhibitor. 27. A composition according to claim 21 or 22 wherein the bioactive agent comprises an antiproliferative.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (112)
von Bittera Miklos (Leverkusen DEX) Meyer Rolf-Volker (Krefeld DEX), Active compound release systems.
Domb Abraham J. (Baltimore MD) Shikani Alain (Baltimore MD) Haffer Andrew S. T. (Baltimore MD) Maniar Manoj (Baltimore MD), Anti-infective and anti-inflammatory releasing systems for medical devices.
Solomon Donald D. (Spring Valley OH) Byron M. Parke (Centerville OH), Anti-infective and antithrombogenic medical articles and method for their preparation.
Solomon Donald D. (Spring Valley OH) Byron M. Parke (Centerville OH), Anti-infective and antithrombogenic medical articles and method for their preparation.
Fearnot Neal E. (West Lafayette IN) Kozma Thomas G. (West Lafayette IN) Ragheb Anthony O. (West Lafayette IN) Voorhees William D. (West Lafayette IN), Coated implantable medical device.
Brem Henry (Lutherville MD) Langer Robert S. (Newton MA) Domb Abraham J. (Efrat ILX), Controlled local delivery of chemotherapeutic agents for treating solid tumors.
Shah Kishore (Bridgewater NJ) Kydonieus Agis (Kendall Park NJ), Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate c.
Eury Robert P. (Cupertino CA) Garguilo Darlene (Fremont CA) Villareal Plaridel (San Jose CA), Drug loaded polymeric material and method of manufacture.
Sabel Bernhard A. (Kreuzberg 6 8011 Egmating MA DEX) Freese Andrew (115 Whitcomb Ave. Jamaica Plain MA 02130), Extended drug delivery of small, water-soluble molecules.
Fox ; Jr. Charles L. (New York NY) Modak Shanta M. (River Edge NJ) Sampath Lester A. (Nyack NY), Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same.
Fischell Robert E. (Silver Spring MD) Fischell Tim A. (Palo Alto CA), Intravascular stent and percutaneous insertion catheter system for the dilation of an arterial stenosis and the preventi.
Tang Reginald T. (Warren NJ) Mares Frank (Whippany NJ) Boyle ; Jr. William J. (Parsippany NJ) Chiu Tin-Ho (Millburn NJ) Patel Kundanbhai M. (Landing NJ), Medical devices fabricated totally or in part from copolymers of recurring units derived from cyclic carbonates and lact.
Shikani Alain H. (Ruxton MD) Domb Abraham J. (Efrat ILX), Method and device for inhibiting H.I.V. hepatitis B and other viruses and germs when using a needle, scalpel and other s.
Sasisekharan Ramnath (Arlington MA) Moses Marsha A. (Brookline MA) Nugent Matthew A. (Bedford MA) Cooney Charles L. (Brookline MA) Langer Robert S. (Newton MA), Method for inhibiting angiogenesis using heparinase.
Good A. Heather (Edmonton CAX) Cooper David K. C. (Oklahoma City OK) Malcolm Andrew J. (Edmonton CAX), Methods and compositions for attenuating antibody-mediated xenograft rejection in human recipients.
Swanson Melvin J. ; Amos Richard A. ; Swan Dale G. ; Opperman Gary W., Photoactivatable chain transfer agents and semi-telechelic photoactivatable polymers prepared therefrom.
Clapper David L. ; Swanson Melvin J. ; Hu Sheau-Ping ; Amos Richard A. ; Everson Terrence P., Polybifunctional reagent having a polymeric backbone and photoreactive moieties and bioactive groups.
Tartaglia Joseph M. (Redwood City CA) Loeffler Joseph P. (Mountain View CA) Turnlund Todd H. (Mountain View CA), Polymer film for wrapping a stent structure.
Dean Laurin ; Angeles Lillian Buan ; Lecon Woo ; Michael T. K. Ling ; Yuan Pang Samuel Ding ; William Anderson ; Larry A. Rosenbaum ; Denise S. Hayward ; Joseph P. Hoppesch ; Gregg Nebgen ;, Polymeric compositions for medical packaging and devices.
Swan Dale G. (St. Louis Park MN) Josephson Mark W. (Richfield MN) Swanson Melvin J. (Carver MN), Preparation of crosslinked matrices containing covalently immobilized chemical species and unbound releasable chemical s.
Guire Patrick E. (Eden Prairie MN) Dunkirk Shawn G. (Eden Prairie MN) Josephson Mark W. (Richfield MN) Swanson Melvin J. (Carver MN), Preparation of polymeric surfaces via covalently attaching polymers.
Duran Lise W. ; Swanson Melvin J. ; Amos Richard A. ; Hu Sheau-Ping J. ; Guire Patrick E., Reagent and method for attaching target molecules to a surface.
Miranda Jesus (Miami FL) Sablotsky Steven (Miami FL), Solubility parameter based drug delivery system and method for altering drug saturation concentration.
Oshlack Benjamin ; Chasin Mark ; Pedi ; Jr. Frank, Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer.
Guire Patrick E. (Eden Prairie MN) Dunkirk Shawn G. (Eden Prairie MN) Josephson Mark W. (Richfield MN) Swanson Melvin J. (Carver MN), Substrate surface preparation.
Aoki ; Y. ; et al. ; "Effects of Recombinant Human Soluble Thrombomodulin (rhs-TM) on a Rat Model of Disseminated Intravascular Coagulation with Decreased Levels of Plasma Antithrombin" Thrombosis an, Surface modifying composition and method.
Weiner Alan L. (Cranbury NJ) Sinnett Kevin (Mukwonago WI) Johnson Sterling (Skillman NJ), Tack for intraocular drug delivery and method for inserting and removing same.
Fearnot Neal E. (West Lafayette IN) Ragheb Anthony O. (West Lafayette IN) Voorhees ; III William D. (West Lafayette IN), Thrombolytic treated intravascular medical device.
Trollsas, Mikael O.; Ngo, Michael Huy; Maslanka, Bozena Zofia; Hossainy, Syed Faiyaz Ahmed; Kleiner, Lothar W., Coating of fast absorption or dissolution.
Glauser, Thierry; Astafieva, Irina; Hossainy, Syed Faiyaz Ahmed, Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug.
Hossainy, Syed F. A.; Trollsas, Mikael; Glauser, Thierry; Tang, Yiwen, Copolymer comprising elastin pentapeptide block and hydrophilic block, and medical device and method of treating.
Ehrenreich, Kevin J.; Newhauser, Richard R.; von Oepen, Randolf; Stankus, John, Expandable member formed of a fibrous matrix for intraluminal drug delivery.
Ehrenreich, Kevin J.; Newhauser, Richard R.; von Oepen, Randolf; Stankus, John, Expandable member formed of a fibrous matrix having hydrogel polymer for intraluminal drug delivery.
Von Oepen, Randolf; Stankus, John; Stamberg, Barbara; Yribarren, Travis R.; Newhauser, Richard R., Expandable member having a covering formed of a fibrous matrix for intraluminal drug delivery.
Pacetti, Stephen D., Implantable medical devices with a topcoat layer of phosphoryl choline acrylate polymer for reduced thrombosis, and improved mechanical properties.
Stone, Corbett W.; Hoey, Michael F.; Gustus, Rolfe Tyson; Perry, Mike; Blanck, Arthur G.; Kunstmanas, Linas R, Inducing desirable temperature effects on body tissue.
Stone, Corbett W.; Hoey, Michael F.; Gustus, Rolfe Tyson; Perry, Mike; Blanck, Arthur G.; Kunstmanas, Linas R., Inducing desirable temperature effects on body tissue.
Herscher, Bret; Krawzsenek, David; LaBarge, Aaron; Espinosa, Joseluis; Perry, Michael, Power generating and control apparatus for the treatment of tissue.
Steinke, Thomas A.; Stone, Corbett W.; Ross, Stephen O.; Kelleher, Brian S.; Michel, Raphael M.; Koenig, Donald H., Selectable eccentric remodeling and/or ablation.
Steinke, Tom A.; Stone, Corbett W.; Ross, Stephen O.; Kelleher, Brian S.; Michel, Raphael M.; Koenig, Donald H., Selectable eccentric remodeling and/or ablation.
Steinke, Tom A.; Stone, Corbett W.; Ross, Stephen O.; Kelleher, Brian S.; Michel, Raphael M.; Koenig, Donald H., Selectable eccentric remodeling and/or ablation of atherosclerotic material.
Ehrenreich, Kevin J.; Newhauser, Richard; von Oepen, Randolf; Stankus, John, Stent delivery system having a fibrous matrix covering with improved stent retention.
Ehrenreich, Kevin J.; Newhauser, Richard; von Oepen, Randolf; Stankus, John J., Stent delivery system having a fibrous matrix covering with improved stent retention.
Stone, Corbett W.; Hoey, Michael F.; Blanck, Arthur G.; Briggs, Len; Perry, Mike; Gustus, Rolfe Tyson, System for inducing desirable temperature effects on body tissue.
Taft, David D.; Bitler, Steven; Zheng, Qiang; Tzannis, Stelios; Bell, Adam; Dai, Wei-Guo; Ottensmann, Sandra N.; Balachander, Natarajan, Systems and methods for delivery of materials.
Stone, Corbett W.; Hoey, Michael F.; Steinke, Tom A.; Michel, Raphael M.; Blanck, Arthur G.; Truesdale, Marlene Kay; Herscher, Bret, Tuned RF energy and electrical tissue characterization for selective treatment of target tissues.
Stone, Corbett W.; Hoey, Michael F.; Steinke, Tom A.; Michel, Raphael M.; Blanck, Arthur G.; Truesdale, Marlene Kay; Herscher, Bret, Tuned RF energy and electrical tissue characterization for selective treatment of target tissues.
Stone, Corbett W.; Hoey, Michael F.; Steinke, Tom A.; Michel, Raphael M.; Blanck, Arthur G., Tuned RF energy for selective treatment of atheroma and other target tissues and/or structures.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.